학술논문
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study
Document Type
Article
Author
Source
In ESMO Open April 2022 7(2)
Subject
Language
ISSN
2059-7029